Minoryx Therapeutics is a private VC-backed company developing innovative therapies for the treatment of orphan CNS (central nervous system) diseases. The molecule MIN-102 is currently in a pivotal Phase 2/3 study for life threatening, orphan chronic subtype adrenomyeloneuropathy (AMN, adult form of X-ALD) and in a Phase 2 study for Friedrich’s Ataxia (FRDA); top line data for both expected by end of 2020 and marketing authorization filing in US/EU will follow. The company was founded in 2011, raised €50m so far and has operations in Spain and Belgium.
Early Drug Development Group is a French interdisciplinary research company bringing together a team of medical oncologists and experts in molecular biology. Our services are mainly aimed at biotechnology and MedTech start-ups or pharmaceutical companies in order to promote research and development programs in oncology quickly and efficiently.
Fleexly is a Belgian one-stop marketplace for freelancers and companies of the pharma, biotech, medtech and healthcare sectors.
Korvis designs and manufactures, in volume, complex machinery and instruments. We provide our customers with tested product, ready to ship to the end user. Our manufacturing services include value engineering and cost cutting manufacturing techniques. Korvis' unique blend of product design and contract manufacturing lowers the overall product cost to its customers.
ProbarE AB conduct clinical trials for drugs that are under development.
We have extensive experience within several medical specialities and a solid track record in conducting clinical trials successfully.
We have had nineteen audits – where sponsors / pharmaceutical companies carefully monitor and control the current and completed studies. We have also had two inspections from the MPA.
Actavia is a game changer in consultancy. All its members are former C-Levels operating in various industries with a key expertise in healthcare, innovation and digital transformation. Based since 8 to 15 years in Asia, they have developed an ecosystem in the region that makes them the perfect partner for your one stop entry point in Asia.
NLO BV BA is a European intellectual property (IP) consulting firm. This firm is part of NLO which is based in The Hague near the European Patent Office (EPO). We advise any start-up, company or university for the best valuation of its innovation. We are specialized in life sciences and electronics, with a focus for telecommunications and inventions related to the application of artificial intelligence. We also have American patent attorneys.
Tools4Patient aims to accelerate patient access to new therapies. We enable the development of new therapies to improve the lives of patients by developing and commercializing data analysis methods and solutions focused on the unique patient response to clinical development therapies. The first technology launched is Placebell, which characterizes patients' placebo response.